Supernus Pharmaceuticals (SUPN) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
0.37
0.64
0.9
1.17

Details

Expected EPS
0.373333
Actual EPS
0.437994
Surprise EPS
0.06
Surprise Percent
+17.32%

Description

⁨Supernus Pharmaceuticals⁩ (⁦SUPN⁩) has reported earnings of ⁦0.437994⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts